The comprehensive study of molecular changes in colorectal cancer identifies potential therapeutic targets. The integrative analysis of distinct molecular sybtypes can led to individualized approach to therapeutics. The predictive and prognostic approach is useful in adjuvant setting and also in treatment selection in metastasic disease in CRC patients.